0 Комментарии
0 Поделились
139 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Reels
-
Статьи пользователей
-
Offers
-
Jobs
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Antiproliferative Drugs Market Grows with Rising Cancer and Transplant TherapiesAccording to the latest report published by Data Bridge Market Research, the Antiproliferative Drugs Market CAGR Valuea This Antiproliferative Drugs Market research report is prepared with detailed statistics and market research insights that results in sharp growth and thriving sustainability in the market for the businesses. This market research report delivers...0 Комментарии 0 Поделились 633 Просмотры 0 предпросмотр
-
Breast Cancer Drugs Market Size, Share and Forecast Report to 2030According to the latest report published by Data Bridge Market Research, the Breast Cancer Drugs Market Data Bridge Market Research analyzes that the global breast cancer drugs market is expected to reach USD 55,996.57 million by 2030 from USD 30,247.54 million in 2022, growing at a CAGR of 8.2% during the forecast period of 2023 to 2030. An international Breast Cancer Drugs...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Can Immune-Modulating Biologic Drugs Redefine Cancer Treatment Worldwide?Executive Summary Immune-Modulating Oncology Biologic Drugs Market Market Size and Share Analysis Report CAGR Value The global immune-modulating oncology biologic drugs market size was valued at USD 10.10 billion in 2025 and is expected to reach USD 28.54 billion by 2033, at a CAGR of13.87% during the forecast period This Immune-Modulating...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Emerging Cancer Drug Technologies Revolutionizing the Anti-cancer Drugs MarketThe Cancer remains one of the leading causes of mortality worldwide, driving pharmaceutical companies and healthcare providers to focus on the development of highly effective anti-cancer drugs. Technological advancements in drug discovery, increased adoption of precision medicine, and favorable regulatory support are accelerating the commercialization of next-generation oncology therapies....0 Комментарии 0 Поделились 842 Просмотры 0 предпросмотр
-
Europe Uterine Cancer Drugs Market Revenue Outlook Supported by Technology Advancements" According to the latest report published by Data Bridge Market Research, the Europe Uterine Cancer Drugs Market The Europe uterine cancer drugs market is expected to reach USD 1,251,870.80 thousand by 2030 from USD 684,672.98 thousand in 2022, growing at a CAGR of 8.4% during the forecast period of 2023 to 2030. The market research data included in this Europe Uterine Cancer...0 Комментарии 0 Поделились 464 Просмотры 0 предпросмотр
-
From Chemotherapy to Targeted Therapies: The Evolution of the Bone Cancer Drugs MarketBone cancer remains one of the most challenging forms of oncology due to its complex diagnosis, aggressive progression, and the need for specialized treatment approaches. Advances in targeted therapies, immunotherapy, precision medicine, and supportive care are transforming treatment outcomes for patients worldwide. Pharmaceutical companies and research organizations continue to invest heavily...0 Комментарии 0 Поделились 349 Просмотры 0 предпросмотр
-
From Chronic Kidney Disease to Cancer Care: The Expanding Role of Erythropoietin DrugsThe increasing prevalence of anemia associated with chronic kidney disease, cancer, and other chronic conditions is driving demand for erythropoietin drugs in the United States. However, the market also faces several challenges. High treatment costs, pricing pressure from biosimilars, safety concerns related to long-term use, and stringent regulatory requirements can affect market...0 Комментарии 0 Поделились 563 Просмотры 0 предпросмотр
-
Gynecological Cancer Drugs Market Trends: Advancements in PARP Inhibitors, Targeted Therapies, and Combination Treatment RegimensThe global Gynecological Cancer Drugs Market is witnessing significant expansion due to the increasing prevalence of gynecological cancers, growing awareness regarding early diagnosis, and continuous advancements in oncology therapeutics. According to market analysis, the Gynecological Cancer Drugs Market size is expected to reach US$ 28.38 billion by 2034 from US$ 15.62 billion in 2025,...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Head And Neck Cancer Drugs Therapeutics Market: How Is Oncologic Innovation Creating Head-Neck Cancer Treatment Infrastructure?Oncologic innovation creating infrastructure — head and neck cancer drugs providing targeted therapy and immunotherapy managing squamous cell carcinoma enabling survival extension, establishing head-neck cancer therapy as essential oncology infrastructure, with the Head And Neck Cancer Drugs Therapeutics Market experiencing expansion driven by head-neck cancer prevalence, treatment...0 Комментарии 0 Поделились 355 Просмотры 0 предпросмотр
-
Hepatocellular Carcinoma Drugs Market Expands Amid Rising Focus on Targeted Cancer Therapies" According to the latest report published by Data Bridge Market Research, the Hepatocellular Carcinoma Drugs Market CAGR Value The global hepatocellular carcinoma drugs market was valued at USD 1.21 billion in 2024 and is expected to reach USD 2.27 billion by 2032 During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of...0 Комментарии 0 Поделились 686 Просмотры 0 предпросмотр
-
Increasing Focus on Cost-Effective Cancer Treatment Accelerates the Generic Oncology Drugs Market GrowthThe global Generic Oncology Drugs Market is witnessing remarkable growth due to the increasing prevalence of cancer worldwide and the rising demand for affordable treatment options. Healthcare systems across developed and emerging economies are actively adopting generic oncology drugs to reduce the financial burden associated with cancer therapies. The growing number of patent expirations for...0 Комментарии 0 Поделились 921 Просмотры 0 предпросмотр
-
Actinic Keratosis Treatment Market Set for Strong Growth Driven by Rising Skin CancerAccording to the latest report published by Data Bridge Market Research, the Actinic Keratosis Treatment Market CAGR Value The idea of this Actinic Keratosis Treatment Market research document is high level analysis of major market segments and recognition of opportunities in Actinic Keratosis Treatment Market industry. Experienced and innovative industry experts...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Are Advanced Therapies Improving Treatment Outcomes for Actinic Keratosis?Executive Summary Actinic Keratosis Treatment Market Market Size and Share Across Top Segments CAGR Value The global actinic keratosis treatment market size was valued at USD 3.36 billion in 2025 and is expected to reach USD 9.02 billion by 2033, at a CAGR of 13.14% during the forecast period Market drivers and market restraints covered in this...0 Комментарии 0 Поделились 4Кб Просмотры 0 предпросмотр
-
Are HER2 Inhibitors Transforming Targeted Therapy in Oncology Treatment?Executive Summary HER2 Inhibitors Market: Share, Size & Strategic Insights CAGR Value The global HER2 inhibitors market size was valued at USD 11.05 billion in 2025 and is expected to reach USD 22.02 billion by 2033, at a CAGR of 9.00% during the forecast period HER2 Inhibitors Market research report works best for the systematic gathering,...0 Комментарии 0 Поделились 4Кб Просмотры 0 предпросмотр
-
Are Immune-Modulating Biologics Redefining the Future of Cancer Immunotherapy?Executive Summary Immune-Modulating Oncology Biologic Drugs Market Size and Share: Global Industry Snapshot CAGR Value The global immune-modulating oncology biologic drugs market size was valued at USD 10.10 billion in 2025 and is expected to reach USD 28.54 billion by 2033, at a CAGR of13.87% during the forecast period The research and analysis...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Blood Cancer Market Size and Revenue Forecast to 2032According to the latest report published by Data Bridge Market Research, the Blood Cancer Market Global blood cancer market size was valued at USD 57.23 billion in 2024 and is projected to reach USD 117.43 billion by 2032, with a CAGR of 9.40% during the forecast period of 2025 to 2032. A team involved in preparing this Blood Cancer Market research report has kept certain things into...0 Комментарии 0 Поделились 5Кб Просмотры 0 предпросмотр
-
Can Advanced Therapies Effectively Combat the Rising Cases of Actinic Keratosis?Market Trends Shaping Executive Summary Actinic Keratosis Treatment Market Size and Share CAGR Value The global actinic keratosis treatment market size was valued at USD 3.36 billion in 2025 and is expected to reach USD 9.02 billion by 2033, at a CAGR of 13.14% during the forecast period A complete discussion about numerous market-related topics...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Can Targeting Endocrine Resistance Unlock New Breakthroughs in Cancer Treatment?Executive Summary Endocrine Resistance–Targeting Drug Market Size and Share Analysis Report CAGR Value The global endocrine resistance–targeting drug market size was valued at USD 2.96 billion in 2025 and is expected to reach USD 8.50 billion by 2033, at a CAGR of 14.10% during the forecast period This Endocrine...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Carcinoid Syndrome Drug Market Gains Momentum with Advancements in Targeted TherapiesAccording to the latest report published by Data Bridge Market Research, the Carcinoid Syndrome Drug Market CAGR Value This Carcinoid Syndrome Drug Market research report is a resource, which offers current as well as upcoming technical and financial details of the Carcinoid Syndrome Drug Market industry for the specific forecast period. The report exhibits important product...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Chemotherapy Induced Peripheral Neuropathy Treatment Market Sees Rising Demand for Advanced TherapiesAccording to the latest report published by Data Bridge Market Research, the Chemotherapy Induced Peripheral Neuropathy Treatment Market CAGR Value Chemotherapy Induced Peripheral Neuropathy Treatment Market report is a great option to achieve current as well as upcoming technical and financial details of the industry to 2027. The report also endows with the strategically...0 Комментарии 0 Поделились 471 Просмотры 0 предпросмотр
Расширенные страницы
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek